Skip to content
Will This Tiny Biotech Be Celgene's Next Takeover Target?
Celgene Could Be Bulking Up Very Fast
Juno Stock Rockets On Report Celgene Could Be In Buyout Talks
The hottest thing in cancer drug development is a takeover target again — here's what you need to know about it (JUNO, CELG)
EIGR Disappoints, EXEL's CELESTIAL Excels, JUNO In CELG's Crosshairs?
Celgene Corp Has Returned 23.5% Since SmarTrend Recommendation (CELG)
Wedbush Downgrades Juno Therapeutics (JUNO) to Neutral Citing Possible CELG Take-out, Says 'Hard to Chase Above Current Levels'
Banque Pictet & Cie SA Has $99.52 Million Stake in Celgene Co. (CELG)
Celgene (NASDAQ:CELG) PT Set at $166.00 by Oppenheimer